STOCK TITAN

Sunshine Biopharma Stock Price, News & Analysis

SBFMW NASDAQ

Company Description

Welcome to the overview page for Sunshine Biopharma (SBFMW), where you can find comprehensive stock information and company updates.

Explore the latest news on strategic partnerships, quarterly and annual financial results, and regulatory filings including SEC reports and insider transactions.

Visualize performance trends using the interactive price chart, and keep track of upcoming events such as earnings calls, dividend dates, and investor conferences.

Stock Performance

$—
0.00%
0.00
Last updated:
-15.25%
Performance 1 year

Financial Highlights

$34.9M
Revenue (TTM)
-$5.1M
Net Income (TTM)
-$12.5M
Operating Cash Flow

Upcoming Events

Short Interest History

Last 12 Months
Loading short interest data...

Short interest in Sunshine Biopharma (SBFMW) currently stands at 2.5 thousand shares, up 11.3% from the previous reporting period, representing 0.1% of the float. Over the past 12 months, short interest has decreased by 64.1%. This relatively low short interest suggests limited bearish sentiment. The 9.0 days to cover indicates moderate liquidity for short covering.

Days to Cover History

Last 12 Months
Loading days to cover data...

Days to cover for Sunshine Biopharma (SBFMW) currently stands at 9.0 days, up 502% from the previous period. This moderate days-to-cover ratio suggests reasonable liquidity for short covering, requiring about a week of average trading volume. The days to cover has increased 768.3% over the past year, indicating either rising short interest or declining trading volume. The ratio has shown significant volatility over the period, ranging from 1.0 to 9.0 days.

Frequently Asked Questions

What is the current stock price of Sunshine Biopharma (SBFMW)?

The current stock price of Sunshine Biopharma (SBFMW) is $0.1695 as of February 27, 2026.

What is the revenue (TTM) of Sunshine Biopharma (SBFMW) stock?

The trailing twelve months (TTM) revenue of Sunshine Biopharma (SBFMW) is $34.9M.

What is the net income of Sunshine Biopharma (SBFMW)?

The trailing twelve months (TTM) net income of Sunshine Biopharma (SBFMW) is -$5.1M.

What is the earnings per share (EPS) of Sunshine Biopharma (SBFMW)?

The diluted earnings per share (EPS) of Sunshine Biopharma (SBFMW) is $-7.32 on a trailing twelve months (TTM) basis. Learn more about EPS .

What is the operating cash flow of Sunshine Biopharma (SBFMW)?

The operating cash flow of Sunshine Biopharma (SBFMW) is -$12.5M. Learn about cash flow.

What is the profit margin of Sunshine Biopharma (SBFMW)?

The net profit margin of Sunshine Biopharma (SBFMW) is -14.7%. Learn about profit margins.

What is the operating margin of Sunshine Biopharma (SBFMW)?

The operating profit margin of Sunshine Biopharma (SBFMW) is -16.7%. Learn about operating margins.

What is the gross margin of Sunshine Biopharma (SBFMW)?

The gross profit margin of Sunshine Biopharma (SBFMW) is 30.6%. Learn about gross margins.

What is the current ratio of Sunshine Biopharma (SBFMW)?

The current ratio of Sunshine Biopharma (SBFMW) is 4.11, indicating the company's ability to pay short-term obligations. Learn about liquidity ratios.

What is the gross profit of Sunshine Biopharma (SBFMW)?

The gross profit of Sunshine Biopharma (SBFMW) is $10.7M on a trailing twelve months (TTM) basis.

What is the operating income of Sunshine Biopharma (SBFMW)?

The operating income of Sunshine Biopharma (SBFMW) is -$5.8M. Learn about operating income.